Simple Science

Cutting edge science explained simply

# Health Sciences # Genetic and Genomic Medicine

The Link Between Diet, Genes, and Mental Health

Exploring how diet and genetics affect mental health and brain diseases.

Lachlan Gilchrist, Julian Mutz, Pirro Hysi, Cristina Legido-Quigley, Sulev Koks, Cathryn M. Lewis, Petroula Proitsi

― 5 min read


Diet and Mental Health Diet and Mental Health Connections mental wellness. New insights reveal diet's impact on
Table of Contents

Mental health issues, like anxiety and depression, often come hand in hand with brain diseases like Alzheimer’s. Scientists have noticed that both types of problems may share similar roots. Genetics appears to play a big part in this. Researchers think that by studying these connections, they can find new ways to help people who suffer from these illnesses.

Metabolomics: A Fancy Word for Studying Tiny Molecules

One way to dig deeper into this connection is through something called metabolomics. This is just a fancy way of saying scientists look at tiny molecules in our bodies that are involved in metabolism. These small bits can tell us a lot about what's going on inside us, especially when it comes to health.

The cool part? Many of these tiny molecules come from the food we eat and have a say in how our bodies function. This means that by analyzing what’s in our blood or urine, scientists can learn how different things might affect mental health and brain diseases.

The Role of Metabolites

A certain group of molecules called metabolites can be super interesting. These include things like fats and amino acids, which play a part in both mental health and brain diseases. For example, some studies show that specific fats are linked to higher risks of depression and other disorders.

However, figuring out if these metabolites are causing problems or if the problems are causing changes in the metabolites can be like a chicken-and-egg situation. To untangle this tricky web, researchers can use a method called Mendelian randomization. It’s a way of using genetics to see if these molecules have a direct impact on our health.

A Closer Look at the Research

Researchers in this study analyzed nearly 1,000 unique plasma metabolites and about 300 ratios involving these metabolites. They looked specifically at four mental health disorders (anxiety, bipolar disorder, depression, and schizophrenia) and four neurodegenerative diseases (like Alzheimer’s and multiple sclerosis).

The goal? To find out which metabolites are particularly important for these different diseases. They used big databases filled with genetic information to see if there were any connections.

What Did They Find?

After all that research, they discovered some interesting things. Many metabolites linked to mental health issues also showed connections to neurodegenerative diseases. For example, Lipids (a type of fat) are often found in both sets of disorders.

Some specific lipids had protective effects, meaning they might help lower the risks of certain mental health issues. Other lipids seemed to increase risk, which is not ideal.

Diving into Lipids

Lipids are not all bad! In fact, some types are actually helpful. For example, certain omega-6 and omega-3 fats can play different roles in our body. Some of these fats might help keep our brain healthy, while others could contribute to inflammation, which can mess with brain function.

The researchers found that having higher levels of some omega-6 fats was linked to a greater risk of mental health issues, while some omega-3s had the opposite effect.

The Power of Glutamine

Another group of molecules researchers looked at was glutamine. Glutamine is an amino acid that seems to have protective effects. Higher levels of glutamine were linked to lower risks of Alzheimer’s. This suggests that keeping glutamine levels up could be an important factor in maintaining brain health.

Sphingolipids: The Unsung Heroes

Sphingolipids are another type of fat that can also play a part in mental health. These lipids are involved in several essential functions, such as controlling inflammation and helping cells communicate. The study found that certain sphingolipids could lower the risk of depression and schizophrenia.

The Role of Diet and Lifestyle

So what does all this mean for you? Well, it turns out that what you eat can have a significant impact on your mental health. Incorporating healthy fats into your diet could be a good move.

You might want to load up on foods rich in omega-3s, like fatty fish (think salmon), and reduce your intake of omega-6 fats found in processed foods (bye-bye, chips!).

The Challenge of Predicting Disease

Even with all this knowledge, predicting who will develop mental health or neurodegenerative disorders is tricky. Researchers tried creating a score based on genetic information to see if it could predict risk, but it didn’t work as well as they hoped.

This area is still a mystery, which means there’s a lot more work to do!

Potential for Interventions

This research points to the possibility that targeting specific metabolites (hello, sphingolipids and glutamine) might be a way to offer new treatments for mental health issues and brain diseases.

It’s like finding out that certain foods can help keep your brain in check. Imagine a future where you could prevent mental health issues just by eating the right snacks!

Final Thoughts: A Journey Ahead

While scientists are uncovering fascinating connections between what we eat, our genes, and our mental health, we’re still at the beginning of this journey. There’s much more to learn, and it will take time to figure out how to best use this knowledge for treatment and prevention.

In the meantime, focusing on a balanced diet full of healthy fats and other nutrients might be one of the easiest ways to support your brain health. After all, a happy brain can lead to a happier life!

Original Source

Title: Evaluating metabolome-wide causal effects on risk for psychiatric and neurodegenerative disorders

Abstract: Evidence indicates phenotypic and biological overlap between psychiatric and neurodegenerative disorders. Further identification of underlying mutual and unique biological mechanisms may yield novel multi-disorder and disorder-specific therapeutic targets. The metabolome represents an important domain for target identification as metabolites play critical roles in modulating a diverse range of biological processes. Here, we used Mendelian randomisation (MR) to test the causal effects of [~]1000 plasma metabolites and [~]300 metabolite ratios on anxiety, bipolar disorder, depression, schizophrenia, amyotrophic lateral sclerosis, Alzheimers disease, Parkinsons disease and multiple sclerosis. In total, 85 causal effects involving 77 unique metabolites passed FDR correction and robust sensitivity analyses (IVW-MR OR range: 0.73-1.48; pFDR < 0.05). No evidence of reverse causality was identified. Multivariate analyses implicated sphingolipid metabolism in psychiatric disorder risk and carnitine derivatives in risk for amyotrophic lateral sclerosis and multiple sclerosis. However, polygenic risk scores for prioritised metabolites showed limited prediction in the UK Biobank. Downstream colocalisation in regions containing influential variants identified greater than suggestive evidence (PP.H4 [&ge;] 0.6) for a shared causal variant for 29 metabolite/psychiatric disorder trait-pairs on chromosome 11 at the FADS gene cluster. Most of these metabolites were lipids containing linoleic or arachidonic acid. Additional colocalisation was identified between the ratio of histidine-to-glutamine, glutamine, Alzheimers disease and SPRYD4 gene expression on chromosome 12. Although no single metabolite had a causal effect on a psychiatric and a neurodegenerative disease, results suggest a broad effect of lipids across brain disorders. Metabolites identified here may help inform future targeted interventions.

Authors: Lachlan Gilchrist, Julian Mutz, Pirro Hysi, Cristina Legido-Quigley, Sulev Koks, Cathryn M. Lewis, Petroula Proitsi

Last Update: 2024-11-07 00:00:00

Language: English

Source URL: https://www.medrxiv.org/content/10.1101/2024.11.06.24316481

Source PDF: https://www.medrxiv.org/content/10.1101/2024.11.06.24316481.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to medrxiv for use of its open access interoperability.

Similar Articles